Skip to content

Analysis of demographic and clinical characteristics of fibrosing mediastinitis

Analysis of demographic and clinical characteristics of fibrosing mediastinitis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000037899
Enrollment
Unknown
Registered
2020-09-04
Start date
2020-09-20
Completion date
Unknown
Last updated
2021-09-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fibrosing mediastinitis

Interventions

case series:Nil

Sponsors

Gansu Provincial Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: According to the pulmonary vascular CTA diagnosis of fibromediastinitis patients, specifically, chest enhanced CT showed that the mediastinal fibrous tissue hyperplasia wrapped and compressed the structure of the mediastinum and bronchial vessels.

Exclusion criteria

Exclusion criteria: 1. Patients with pulmonary hypertension from the first to the fourth categories; 2. Patients with lung tumor, mediastinal or hilar metastasis, suspected mediastinal necrotizing granulomatous lymphadenitis, systemic sclerosis, etc; 3. Patients with diffuse fibromediastinitis (patients with extrapulmonary diseases such as retroperitoneal fibrosis and sclerosing cholangitis, IgG4 positive patients).

Design outcomes

Primary

MeasureTime frame
NT-proBNP;cTnT;Mean pulmonary artery pressure;Pulmonary artery systolic pressure;Cardiac output;6-minute walk distance;WHO functional class;

Countries

China

Contacts

Public ContactYunshan Cao

Gansu Provincial Hospital

yunshancao@126.com+86 13669306699

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026